Sotiriou C - Search Results

1

Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).

Condorelli R, Mosele F, Verret B, Bachelot T, Bedard PL, Cortes J, Hyman DM, Juric D, Krop I, Bieche I, Saura C, Sotiriou C, Cardoso F, Loibl S, Andre F, Turner NC. Condorelli R, et al. Among authors: sotiriou c. Ann Oncol. 2019 Mar 1;30(3):365-373. doi: 10.1093/annonc/mdz036. Ann Oncol. 2019. PMID: 30715161 Free article.

2

Predictive molecular markers in the adjuvant therapy of breast cancer: state of the art in the year 2002.

Di Leo A, Cardoso F, Durbecq V, Giuliani R, Mano M, Atalay G, Larsimont D, Sotiriou C, Biganzoli L, Piccart MJ. Di Leo A, et al. Among authors: sotiriou c. Int J Clin Oncol. 2002 Aug;7(4):245-53. doi: 10.1007/s101470200036. Int J Clin Oncol. 2002. PMID: 12202978 Review.

3

Correlation between complete response to anthracycline-based chemotherapy and topoisomerase II-alpha gene amplification and protein overexpression in locally advanced/metastatic breast cancer.

Cardoso F, Durbecq V, Larsimont D, Paesmans M, Leroy JY, Rouas G, Sotiriou C, Renard N, Richard V, Piccart MJ, Di Leo A. Cardoso F, et al. Among authors: sotiriou c. Int J Oncol. 2004 Jan;24(1):201-9. Int J Oncol. 2004. PMID: 14654958

4

New data on chemotherapy in the adjuvant setting.

Piccart MJ, Sotiriou C, Cardoso F. Piccart MJ, et al. Among authors: sotiriou c. Breast. 2003 Dec;12(6):373-8. doi: 10.1016/s0960-9776(03)00139-5. Breast. 2003. PMID: 14659108

5

Molecular profiling of head and neck tumors.

Sotiriou C, Lothaire P, Dequanter D, Cardoso F, Awada A. Sotiriou C, et al. Curr Opin Oncol. 2004 May;16(3):211-4. doi: 10.1097/00001622-200405000-00003. Curr Opin Oncol. 2004. PMID: 15069314 Review.

6

Targeting the ubiquitin-proteasome pathway in breast cancer.

Cardoso F, Ross JS, Picart MJ, Sotiriou C, Durbecq V. Cardoso F, et al. Among authors: sotiriou c. Clin Breast Cancer. 2004 Jun;5(2):148-57. doi: 10.3816/cbc.2004.n.020. Clin Breast Cancer. 2004. PMID: 15245620 Review.

7

Gene regulation by phorbol 12-myristate 13-acetate in MCF-7 and MDA-MB-231, two breast cancer cell lines exhibiting highly different phenotypes.

Lacroix M, Haibe-Kains B, Hennuy B, Laes JF, Lallemand F, Gonze I, Cardoso F, Piccart M, Leclercq G, Sotiriou C. Lacroix M, et al. Among authors: sotiriou c. Oncol Rep. 2004 Oct;12(4):701-7. doi: 10.3892/or.12.4.701. Oncol Rep. 2004. PMID: 15375488

8

Correlation between topoisomerase-IIalpha gene amplification and protein expression in HER-2 amplified breast cancer.

Durbecq V, Desmed C, Paesmans M, Cardoso F, Di Leo A, Mano M, Rouas G, Leroy JY, Sotiriou C, Piccart M, Larsimont D. Durbecq V, et al. Among authors: sotiriou c. Int J Oncol. 2004 Nov;25(5):1473-9. doi: 10.3892/ijo.25.5.1473. Int J Oncol. 2004. PMID: 15492841

9

Potential predictive value of Bcl-2 for response to tamoxifen in the adjuvant setting of node-positive breast cancer.

Cardoso F, Paesmans M, Larsimont D, Durbecq V, Bernard-Marty C, Rouas G, Dolci S, Sotiriou C, Piccart MJ, Di Leo A. Cardoso F, et al. Among authors: sotiriou c. Clin Breast Cancer. 2004 Dec;5(5):364-9. doi: 10.3816/cbc.2004.n.043. Clin Breast Cancer. 2004. PMID: 15585074

10

Challenges in breast cancer clinical trial design in the postgenomic era.

Loi S, Buyse M, Sotiriou C, Cardoso F. Loi S, et al. Among authors: sotiriou c. Curr Opin Oncol. 2004 Nov;16(6):536-41. doi: 10.1097/01.cco.0000142925.99075.a0. Curr Opin Oncol. 2004. PMID: 15627014 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

406 results

Search Page

Filters